Musculoskeletal and Neuromuscular Impairments in Myalgic Encephalomyelitis (ME)

Purpose

This document explains the musculoskeletal and neuromuscular impairments associated with Myalgic Encephalomyelitis (ME), as defined by the International Consensus Criteria (ICC). It highlights how these symptoms relate to broader neurological and immune dysfunction and outlines supportive management approaches.

Key Points

1. Nature of Musculoskeletal and Neuromuscular Impairment

• These impairments are considered part of the neurological dysfunction seen in ME.
• They are not caused by deconditioning but are linked to underlying neuroimmune disruption.
• Symptoms often worsen after physical or cognitive exertion due to post‑exertional neuroimmune exhaustion (PENE).

2. Muscle Weakness and Fatigability

• Reduced muscle strength and loss of power are common.
• Muscles fatigue quickly and take a long time to recover.
• Even minor activity can lead to prolonged weakness.

3. Pain and Sensitivity

• Muscle pain, tenderness, and myofascial discomfort are frequent.
• Joint pain may occur without visible inflammation.
• Sensitivity to touch or pressure can affect movement and physical comfort.

4. Movement and Coordination Issues

• Impaired coordination, balance problems, and clumsiness may occur.
• Some individuals experience slowed movement and reduced motor control.
• Severe cases may involve temporary immobility after exertion.

5. Neuromuscular Symptoms

• Muscle twitching, tremors, spasms, or fasciculations may be present.
• Limbs may feel heavy or difficult to move.
• Motor processing can feel delayed or inefficient.

6. Symptom Fluctuation

• Severity of symptoms can vary significantly day to day.
• Physical, cognitive, or sensory exertion can trigger worsening of symptoms.

7. Management Approaches

Energy Management

• Pacing is essential to stay within individual limits and avoid crashes.
• Activities should be broken into smaller, manageable tasks.

Pain and Symptom Relief

• Gentle, tolerance-based approaches such as heat, light stretching, or adapted physiotherapy may help.
• Medications may be used under medical supervision where necessary.

Mobility and Support Aids

• Tools such as canes, wheelchairs, braces, or shower chairs can reduce strain and conserve energy.

Supportive Care

• Improving sleep quality may reduce pain and fatigue.
• Addressing autonomic issues (such as orthostatic intolerance) may improve physical function.
• Nutritional support may help if deficiencies are present.

Activity and Rehabilitation

• Any movement should remain below symptom-triggering thresholds.
• Traditional graded exercise approaches may worsen symptoms and should be avoided.

Environmental Adjustments

• Reducing sensory overload, prolonged standing, and environmental stressors can help limit symptom worsening.

Target Audience

• Individuals diagnosed with ME/CFS
• Caregivers and family members
• Healthcare professionals supporting ME patients
• Researchers examining neuromuscular and neurological dysfunction

Overall Outcome

Musculoskeletal and neuromuscular impairments are a core component of ME and reflect underlying neurological and immune dysfunction rather than simple physical deconditioning. These symptoms significantly impact mobility, strength, and daily functioning. Effective management focuses on pacing, symptom control, and individualized support to minimise post‑exertional worsening and improve overall quality of life.